SCHEMBL24925770

SCHEMBL24925770

COc1cccc([C@H](C)[C@H](C)O)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KCNH2 Q12809 1/20 0.42
TAAR1 Q96RJ0 2/20 0.38
HRH1 P35367 1/20 0.38
ROCK2 O75116 3/20 0.36
ROCK1 Q13464 2/20 0.36
KCNA5 P22460 1/20 0.36
KCNB1 Q14721 1/20 0.36
IDH1 O75874 1/20 0.35
BTK Q06187 1/20 0.35
KDR P35968 1/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38661913 0.85 CYP3A4 (0.44) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL4196024 0.85 CYP3A4 (0.44) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL8865877 0.82 CYP3A4 (0.45) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL20738701 0.82 CYP3A4 (0.40) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL29337164 0.82 TAAR1 (0.43) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL179528 0.80 TAAR1 (0.42) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL2936969 0.77 TAAR1 (0.54) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL20738487 0.77 TAAR1 (0.40) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL29793607 0.77 TAAR1 (0.54) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL38661915 0.77 CYP3A4 (0.44) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS MAPK1, ALK, MAP3K1 CYP3A4 2243/4885CYP2D6 1108/4885SLC6A2 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.